Unresectable Locally Advanced Pancreatic Cancer: A Multimodal Treatment Using Neoadjuvant Chemoradiotherapy (Gemcitabine Plus Stereotactic Radiosurgery) and Subsequent Surgical Exploration

[1] Roazzi P(2003)Carrani E; EUROCARE Working Group. Elecronic availability of EUROCARE-3 data: a tool for further analysis Ann Oncol 14 v150-v155

[2] Capocaccia R(1999)Pancreatic cancer: a report of treatment and survival trends for 100, 313 patients diagnosed from 1985–1995, using the National Cancer Database J Am Coll Surg 189 1-7

[3] Santaquilani M(2004)Current standards of surgery for pancreatic cancer Br J Surg 91 1410-1427

[4] Sener SF(1993)An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging Cancer 72 2118-2123

[5] Fremgen A(2010)Induction chemotherapy followed by chemoradiation in locally advanced pancreatic cancer: an effective and well-tolerated treatment Clin Oncol (R Coll Radiol) 22 27-35

[6] Menck HR(2009)Neoadjuvant chemoradiation and pancreaticoduodenectomy for initially advanced head pancreatic adenocarcinoma Eur J Surg Oncol 35 1306-1311

[7] Winchester DP(2004)Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer Int J Radiat Oncol Biol Phys 58 1017-1021

[8] Alexakis N(2000)New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 205-216

[9] Halloran C(1981)Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil. The Gastrointestinal Tumor Study Group Cancer 48 1705-1710

[10] Raraty M(2004)Pancreatic cancer Dis Mon 50 545-555

[1] Roazzi P(2003)Carrani E; EUROCARE Working Group. Elecronic availability of EUROCARE-3 data: a tool for further analysis Ann Oncol 14 v150-v155

[2] Capocaccia R(1999)Pancreatic cancer: a report of treatment and survival trends for 100, 313 patients diagnosed from 1985–1995, using the National Cancer Database J Am Coll Surg 189 1-7

[3] Santaquilani M(2004)Current standards of surgery for pancreatic cancer Br J Surg 91 1410-1427

[4] Sener SF(1993)An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging Cancer 72 2118-2123

[5] Fremgen A(2010)Induction chemotherapy followed by chemoradiation in locally advanced pancreatic cancer: an effective and well-tolerated treatment Clin Oncol (R Coll Radiol) 22 27-35

[6] Menck HR(2009)Neoadjuvant chemoradiation and pancreaticoduodenectomy for initially advanced head pancreatic adenocarcinoma Eur J Surg Oncol 35 1306-1311

[7] Winchester DP(2004)Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer Int J Radiat Oncol Biol Phys 58 1017-1021

[8] Alexakis N(2000)New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 205-216

[9] Halloran C(1981)Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil. The Gastrointestinal Tumor Study Group Cancer 48 1705-1710

[10] Raraty M(2004)Pancreatic cancer Dis Mon 50 545-555